Indication
Maintenance Therapy
4 clinical trials
5 products
1 drug
Clinical trial
Maintenance Therapy With Toripalimab Combined With Capecitabine Versus Maintenancetherapy With Capecitabine Alone in High-risk Nasopharyngeal Carcinoma: a Multicenter, Prospective, Randomized Phase III Clinical Trial (NPC-ICMB)Status: Recruiting, Estimated PCD: 2029-02-20
Product
Toripalimab + CapecitabineProduct
CapecitabineClinical trial
The Efficacy and Safety of Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma:Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical StudyStatus: Recruiting, Estimated PCD: 2026-04-28
Clinical trial
Zanubrutinib for Maintenance Therapy in Patients With Mantle Cell Lymphoma Who Have Remission After First-line Immunochemotherapy- a Multicenter, Prospective, Phase II StudyStatus: Recruiting, Estimated PCD: 2026-03-01
Drug
ZanubrutinibClinical trial
A Prospective, Open-label, Controlled, Single Center Clinical Study of the Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated VasculitisStatus: Recruiting, Estimated PCD: 2025-12-31
Product
AzathioprineProduct
Telitacicept